医学部・消化器外科学

Medicine and Dentistry

1. Hepatectomy 100%
2. Neoplasm 59%
3. Surgery 37%
4. Cancer 23%
5. Liver Cirrhosis 22%
6. Propensity Score Matching 21%
7. Portal Hypertension 21%
8. Surgeon 19%
9. Systematic Review 18%
10. Malignant Neoplasm 17%
11. Bleeding 16%
12. Hepatocellular Carcinoma 16%
13. Blood Transfusion 14%
14. Liver Surgery 13%
15. Recurrent Disease 13%
16. Pancreaticoduodenectomy 13%
17. Operation Duration 11%
18. Pancreas Fistula 10%
19. Tricaprilin 10%
20. Breathing 10%
21. Carbon 13 10%
22. Neoadjuvant Chemotherapy 10%
23. Body Mass Index 10%
24. Gastrointestinal Surgery 10%
25. Cancer Surgery 10%
26. Anatomy 10%
27. Multivariate Analysis 9%
28. Artery 8%
29. COVID-19 8%
30. Pancreas Cancer 8%
31. Scoring System 7%
32. Pancreatectomy 7%
33. Liver Metastasis 6%
34. Pancreas Adenocarcinoma 6%
35. Common Hepatic Artery 6%
36. Retroperitoneal Lymph Node Dissection 6%
37. Gemcitabine 6%
38. Hepatic Vein 6%
39. Adjuvant Therapy 6%
40. Pringle Manoeuvre 5%
41. Post-Hoc Analysis 5%
42. Metastatic Carcinoma 5%
43. Pancreas Tumor 5%
44. Immunoglobulin G4 5%
45. Metastatic Colorectal Cancer 5%
46. Magnetic Resonance Cholangiopancreatography 5%
47. Tumor Thrombus 5%
48. Conception 5%
49. Sigmoid Cancer 5%
50. Superior Mesenteric Artery 5%
51. Gastrointestinal Stromal Tumor 5%
52. Conversion Therapy 5%
53. Colorectal Liver Metastasis 5%
54. Lymphadenitis 5%
55. Phlegmon 5%
56. Radiation Therapy 5%
57. Stapes 5%
58. Rectum Cancer 5%
59. Phase II Trials 5%
60. Imatinib 5%
61. Hepatocyte Transplantation 5%
62. Edaravone 5%
63. Scavenger 5%
64. Hepatic Portal Vein 5%
65. Plasma Cell Granuloma 5%
66. Surgical Infection 5%
67. Mucinous Carcinoma 5%
68. Intraductal Papillary Mucinous Tumor 5%
69. Hernia Surgery 5%
70. Subfascial Endoscopic Perforator Surgery 5%
71. Bile Duct Stone 5%
72. Cluster Randomized Trial 5%
73. Colon Cancer 5%
74. Steroid Therapy 5%
75. Pancreas Function 5%
76. Lithotomy 5%
77. Arm 5%
78. Neuroendocrine Tumor 5%
79. Perioperative Period 5%
80. Meta-Analysis 5%
81. Lenvatinib 5%
82. Endoscopic Surgery 5%
83. Sclerosing Cholangitis 5%

Keyphrases

1. Minimally Invasive 10%
2. International multicenter Study 10%
3. Pancreaticoduodenectomy 10%
4. IgG4-related Sclerosing Cholangitis 10%
5. Postoperative Outcomes 9%
6. Robotics 8%
7. Tumor 7%
8. Open Conversion 6%
9. Cirrhosis 6%
10. Laparoscopic Hepatectomy 6%
11. Steroid Treatment 6%
12. Minimally Invasive Liver Surgery 6%
13. Liver Resection 6%
14. Multivariate Analysis 5%
15. Gallbladder Cancer 5%
16. National Clinical Database 5%
17. Japan 5%
18. Laparoscopic Approach 5%
19. Gastroenterological Surgery 5%
20. Surgical Outcomes 5%
21. TAS-102 5%
22. Chemotherapy 5%
23. FOLFIRINOX 5%
24. Liver Cirrhosis 5%
25. Paradoxical Results 5%
26. Advanced Dressing 5%
27. Conversion Surgery 5%
28. Guideline Revision 5%
29. Nonfunctioning 5%
30. Duodenal Gastrointestinal Stromal Tumors 5%
31. Major Hepatectomy 5%
32. Liver Malignancy 5%
33. Pancreatic Fistula 5%
34. Glissonean Approach 5%
35. Hepatic Artery 5%
36. Superior Mesenteric Artery 5%
37. Conversion Therapy 5%
38. Resectable Pancreatic Cancer 5%
39. Minimally Invasive Distal Pancreatectomy 5%
40. Leonardo Da Vinci 5%
41. S-system 5%
42. Promising Treatment 5%
43. Intracholecystic Papillary Neoplasm 5%
44. Inguinal Hernioplasty 5%
45. Phlegmon 5%
46. Exocrine Function 5%
47. Hepatic Artery Resection 5%
48. Hepatocyte Transplantation 5%
49. Histological Remission 5%
50. Radical Scavenger 5%
51. Cancer Risk 5%
52. Risk Outcomes 5%
53. Edaravone 5%
54. Rehepatectomy 5%
55. Breath Test 5%
56. Inferior Pancreaticoduodenal Artery 5%
57. Risk Factors 5%
58. Subfascial Endoscopic Perforator Surgery 5%
59. Elective Care 5%
60. Hernia Surgery 5%
61. Metachronous Liver Metastasis 5%
62. Stirrups 5%
63. Right Colectomy 5%
64. Pancreatic Neuroendocrine Tumors (pNETs) 5%
65. Robotic Approach 5%
66. Steroid Therapy 5%
67. HPB Surgery 5%
68. Propensity Score Analysis 5%
69. Borderline Resectable Pancreatic Cancer 5%
70. Hepatectomy 5%
71. Quality Improvement Intervention 5%
72. Stepped-wedge Trial 5%
73. Marginal Livers 5%
74. Left Lateral Sectionectomy 5%
75. Anterolateral Segments 5%
76. Body Mass Index 5%
77. New Treatment Options 5%
78. Portal Hypertension 5%
79. Pure Laparoscopic Hepatectomy 5%
80. Pancreatic Colloid Carcinoma 5%
81. Global Benchmark 5%
82. Tactile Sensor 5%
83. Radiation Therapy 5%
84. Eosinophilic Count 5%